David Owens

Dr. Owens has been associated with Nexalin Technology for seven years and was named Chief Medical Officer in December 2017. He brings extensive experience in neuro-technologies and treatment methodologies gained over more than his 3 decades in neuroradiology and neuroimaging. Dr Owens oversees all clinical trial designs and manages oversight of all existing and future Nexalin providers.